Tuesday, 1 April 2008

Teva to appeal against decision On generic Lansoprazole

Teva Pharma announced that the U.S. District Court for the District of Delaware has delivered its decision in the case related to the its Abbreviated New Drug Application (ANDA) for marketing the generic version of the Prevacid (Lansoprazole) Delayed Release Capsules 15 mg and 30 mg, saying that the patent is valid and enforceable. The company said it intends to appeal against the court decision

Posted by ADKS at 3:01 pm

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker